Kidney Research and Clinical Practice

Serum and urine metabolomic biomarkers for predicting prognosis in patients with immunoglobulin A nephropathy: You Hyun Jeon, Sujin Lee, Da Woon Kim et al.; Received July 7, 2022 Accepted November 28, 2022 Published online May 18, 2023; [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy: Young Su Joo, Hyung Woo Kim, Chung Hee Baek et al.; Kidney Res Clin Pract. 2022;41(5):556-566. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.22.006; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Quality of life in patients with diabetic nephropathy: findings from the KNOW-CKD (Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease) cohort: Hyunsuk Kim, Joongyub Lee, Gwang Ho Choi et al.; Kidney Res Clin Pract. 2022;41(1):43-57. Published online November 8, 2021; DOI: https://doi.org/10.23876/j.krcp.21.068; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy: Ji-Hye Lee, Si-Hyong Jang, Nam-Jun Cho et al.; Kidney Res Clin Pract. 2020;39(3):295-304. Published online September 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.017
Cited By 4; Full text PubReader Crossref - TDM PDF

Dihydroxyadenine crystal-induced nephropathy presenting with rapidly progressive renal failure: Ritu Verma, Manickam Niraimathi, Pallavi Prasad, Vinita Agrawal; Kidney Res Clin Pract. 2018;37(3):287-291. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.287
Cited By 7; Full text PubReader Crossref - TDM PDF

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy: Eun Joo Song, Kye Hwa Jeong, Young Ae Yang et al.; Kidney Res Clin Pract. 2018;37(3):248-256. Published online September 30, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.3.248
Cited By 10; Full text PubReader Crossref - TDM PDF

Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy: Sergey V. Brodsky, Nilesh S. Mhaskar, Sampath Thiruveedi et al.; Kidney Res Clin Pract. 2017;36(4):387-392. Published online December 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.4.387
Cited By 37; Full text PubReader Crossref - TDM PDF

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial: Keiji Hirai, Susumu Ookawara, Taisuke Kitano et al.; Kidney Res Clin Pract. 2017;36(2):159-166. Published online June 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.2.159
Cited By 3; Full text PubReader Crossref - TDM PDF

A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis: Kyung-Yil Lee; Kidney Res Clin Pract. 2017;36(2):132-144. Published online June 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.2.132
Cited By 11; Full text PubReader Crossref - TDM PDF

The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy: Hyung Ah Jo, Joo-Young Kim, Seung Hee Yang et al.; Kidney Res Clin Pract. 2016;35(4):212-218. Published online September 17, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.09.003
Cited By 22; Full text PubReader Crossref - TDM PDF

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy: Shuntaro Maruyama, Tomohito Gohda, Yusuke Suzuki et al.; Kidney Res Clin Pract. 2016;35(4):233-236. Published online September 16, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.09.002
Cited By 5; Full text PubReader Crossref - TDM PDF

Diagnosis and treatment of patients with IgA nephropathy in Japan: Yasuhiko Tomino; Kidney Res Clin Pract. 2016;35(4):197-203. Published online September 15, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.09.001
Cited By 24; Full text PubReader Crossref - TDM PDF

8,690	Recent advances in electron microscopy for the diagnosis and research of glomerular diseases
30,993	Uremic pruritus: pathophysiology, clinical presentation, and treatments
5,550	Updates in renal pathology
8,492	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
1,779	Zebra bodies in lupus nephritis after hydroxychloroquine therapy

Cited By 39	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 20	Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
Cited By 13	Intestinal microbiota and kidney diseases
Cited By 11	Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study
Cited By 10	Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis

Search